Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Exercise / conversionCommon Stock | 3,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011278 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,533.64 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 19,343 | $59.86 | $1,157,871.98 |
DisclosureSEC source: 0001225208-15-011279 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,343 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Tax withholdingCommon Stock | 8,709 | $59.86 | $521,320.74 |
DisclosureSEC source: 0001225208-15-011279 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,634 Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 19,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011279 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantStock Option (right to buy) · Derivative | 142,415 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · derivative · entry 5 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,415 Underlying: Common Stock · 142,415 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantStock Option (right to buy) · Derivative | 30,960 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011271 · doc4.xml · derivative · entry 4 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,960 Underlying: Common Stock · 30,960 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 2,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011271 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,506 Underlying: Common Stock · 2,506 shares Expires 2018-05-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 99,071 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,071 Underlying: Common Stock · 99,071 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantStock Option (right to buy) · Derivative | 86,687 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011273 · doc4.xml · derivative · entry 4 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,687 Underlying: Common Stock · 86,687 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
GrantStock Option (right to buy) · Derivative | 49,536 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011274 · doc4.xml · derivative · entry 3 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,536 Underlying: Common Stock · 49,536 shares Expires 2025-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantStock Option (right to buy) · Derivative | 46,440 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011275 · doc4.xml · derivative · entry 4 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,440 Underlying: Common Stock · 46,440 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 105,263 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011276 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,263 Underlying: Common Stock · 105,263 shares Expires 2025-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantStock Option (right to buy) · Derivative | 37,152 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011277 · doc4.xml · derivative · entry 4 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,152 Underlying: Common Stock · 37,152 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantRestricted Stock Unit · Derivative | 3,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011277 · doc4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007 Underlying: Common Stock · 3,007 shares Expires 2018-05-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 46,440 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011278 · doc4.xml · derivative · entry 3 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,440 Underlying: Common Stock · 46,440 shares Expires 2025-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 235,294 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011279 · doc4.xml · derivative · entry 4 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,294 Underlying: Common Stock · 235,294 shares Expires 2025-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 743,034 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011280 · doc4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743,034 Underlying: Common Stock · 743,034 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 247,678 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011281 · doc4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,678 Underlying: Common Stock · 247,678 shares Expires 2025-04-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Holston Michael JEVP, Legal
|
GrantStock Option (right to buy) · Derivative | 123,839 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011282 · doc4.xml · derivative · entry 2 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,839 Underlying: Common Stock · 123,839 shares Expires 2025-04-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC |
Davis Robert MExec V-P & Chief Fince Officer
|
GrantStock Option (right to buy) · Derivative | 216,718 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011283 · doc4.xml · derivative · entry 1 Davis Robert M · CIK 0001363076 · Exec V-P & Chief Fince Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,718 Underlying: Common Stock · 216,718 shares Expires 2025-04-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 44,776 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · derivative · entry 6 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,776 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 112,126 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · derivative · entry 5 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,064 Underlying: Common Stock · 112,126 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
SaleCommon Stock | 91,596 | $60.00 | $5,495,760.00 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · nonDerivative · entry 4 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,795.143 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.8600 to $60.4100, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
SaleCommon Stock | 65,306 | $59.58 | $3,890,885.77 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · nonDerivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,391.143 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.2600 to $59.8500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 44,776 | $36.56 | $1,637,010.56 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · nonDerivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,697.143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 112,126 | $39.29 | $4,405,430.54 |
DisclosureSEC source: 0001225208-15-010603 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,921.143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Holston Michael JEVP, Legal
|
Exercise / conversionStock Option (right to buy) · Derivative | 114,154 | $0.00 Strike: $44.28 | $0.00 |
DisclosureSEC source: 0001225208-15-010604 · doc4.xml · derivative · entry 5 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,079 Underlying: Common Stock · 114,154 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable in equal installments on 8/1/2013, 8/1/2014 and 8/1/2015. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Holston Michael JEVP, Legal
|
Exercise / conversionStock Option (right to buy) · Derivative | 21,470 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-15-010604 · doc4.xml · derivative · entry 4 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,942 Underlying: Common Stock · 21,470 shares Expires 2023-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option becomes exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Holston Michael JEVP, Legal
|
SaleCommon Stock | 95,624 | $59.84 | $5,722,541.78 |
DisclosureSEC source: 0001225208-15-010604 · doc4.xml · nonDerivative · entry 3 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.7550 to $59.9400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Holston Michael JEVP, Legal
|
Exercise / conversionCommon Stock | 21,470 | $44.98 | $965,720.60 |
DisclosureSEC source: 0001225208-15-010604 · doc4.xml · nonDerivative · entry 2 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2015 Filed Apr 29, 2015 22:01 UTC |
Holston Michael JEVP, Legal
|
Exercise / conversionCommon Stock | 114,154 | $44.28 | $5,054,739.12 |
DisclosureSEC source: 0001225208-15-010604 · doc4.xml · nonDerivative · entry 1 Holston Michael J · CIK 0001390613 · EVP, Legal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2015 Filed Apr 13, 2015 21:24 UTC |
HARRISON WILLIAM B JRDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-15-009975 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008. Read SEC document |
| April 13, 2015 Filed Apr 13, 2015 21:24 UTC |
HARRISON WILLIAM B JRDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.83 | $169,150.00 |
DisclosureSEC source: 0001225208-15-009975 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 21:25 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 630.6541 | $57.48 | $36,250.00 |
DisclosureSEC source: 0001225208-15-009023 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,874.2974 Underlying: Common Stock · 630.6541 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 21:25 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 434.9339 | $57.48 | $25,000.00 |
DisclosureSEC source: 0001225208-15-009024 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,663.9846 Underlying: Common Stock · 434.9339 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 21:27 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 478.4273 | $57.48 | $27,500.00 |
DisclosureSEC source: 0001225208-15-009025 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,652.4566 Underlying: Common Stock · 478.4273 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 21:27 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 434.9339 | $57.48 | $25,000.00 |
DisclosureSEC source: 0001225208-15-009026 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,792.2146 Underlying: Common Stock · 434.9339 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:26 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantCommon Stock | 2,462 | $58.30 | $143,534.60 |
DisclosureSEC source: 0001225208-15-005600 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,844.553 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:26 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 84,836 | $58.30 | $4,945,938.80 |
DisclosureSEC source: 0001225208-15-005601 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,236.063 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantCommon Stock | 8,762 | $58.30 | $510,824.60 |
DisclosureSEC source: 0001225208-15-005602 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,992.2077 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantCommon Stock | 6,649 | $58.30 | $387,636.70 |
DisclosureSEC source: 0001225208-15-005603 · doc4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,401 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
GrantCommon Stock | 2,736 | $58.30 | $159,508.80 |
DisclosureSEC source: 0001225208-15-005604 · doc4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,374.436 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantCommon Stock | 1,466 | $58.30 | $85,467.80 |
DisclosureSEC source: 0001225208-15-005605 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,980.12 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantCommon Stock | 11,190 | $58.30 | $652,377.00 |
DisclosureSEC source: 0001225208-15-005606 · doc4.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,843.64 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantCommon Stock | 14,282 | $58.30 | $832,640.60 |
DisclosureSEC source: 0001225208-15-005607 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,670.686 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantCommon Stock | 22,198 | $58.30 | $1,294,143.40 |
DisclosureSEC source: 0001225208-15-005609 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,198 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantCommon Stock | 5,001 | $58.30 | $291,558.30 |
DisclosureSEC source: 0001225208-15-005608 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,477.447 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 18, 2015 Filed Feb 18, 2015 21:51 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,082 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-15-004508 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,082 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008. Read SEC document |
| February 18, 2015 Filed Feb 18, 2015 21:51 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 5,164 | $58.67 | $302,958.97 |
DisclosureSEC source: 0001225208-15-004508 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,400.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.6001 to $58.7600, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 18, 2015 Filed Feb 18, 2015 21:51 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 7,082 | $31.84 | $225,490.88 |
DisclosureSEC source: 0001225208-15-004508 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,564.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.